Healthcare Triangle, Inc. (NASDAQ: HCTI) completed the issuance of 12,546,540 shares of common stock on July 24, 2026, in connection with two previously shareholder-approved transactions: an acquisition involving Teyame AI LLC and a Share Exchange Agreement with SecureKloud Technologies Ltd.

Following the issuances, the company's total shares outstanding as of July 28, 2026, reached 14,644,322. Based on a closing stock price of $1.63 per share on that date, the company's Market Value of Listed Securities (MVLS) was approximately $23,870,244.

The share issuances come after the U.S. Securities and Exchange Commission approved a new Nasdaq continued listing requirement on July 22, 2026, establishing a minimum MVLS of $5 million for all Nasdaq-listed companies.

David Ayanoglou, Chief Financial Officer of Healthcare Triangle, said: "The completion of the Legacy Transactions marks an important step in HCTI's growth strategy. These issuances also meaningfully strengthen our position under Nasdaq's new listing standard, giving our shareholders added confidence in the Company's continued listing on the Nasdaq Global Market."

The company noted that the press release does not constitute confirmation from Nasdaq of its compliance status, as compliance determinations are made by Nasdaq based on daily closing bid price and total shares listed.